TL;DR
Azelaic acid at 15–20% is one of the few topicals with FDA approval for two conditions at once: mild-to-moderate acne and papulopustular rosacea. By the evidence it's comparable to tretinoin for acne, gentler than retinoids on tolerability, and considered safe during pregnancy. Cosmetic 5–10% formulations don't deliver the same therapeutic effect – the trials that matter were run at pharmacy strength.
What it is and how it works
Azelaic acid is a dicarboxylic acid produced naturally by the yeast Malassezia furfur. Topically it acts through four independent mechanisms:
- Antibacterial – suppresses Cutibacterium acnes, the bacterium that colonises clogged pores. It does not work as an antibiotic, so resistance does not develop.
- Anti-inflammatory – neutralises the reactive oxygen species neutrophils release around inflamed follicles, which reduces the redness halo around papules.
- Keratolytic – normalises follicular hyperkeratinisation, so pores stay clearer.
- Tyrosinase inhibition – blocks the enzyme that synthesises melanin. That's why it works on post-acne marks and post-inflammatory hyperpigmentation.
The point is not any single mechanism. It's that all four run in parallel, which is why one ingredient covers four cosmetology problems.
For more on the molecule and concentrations: azelaic acid.
The evidence by indication
Acne (mild and moderate)
Cunliffe & Holland, 1989 (Acta Dermato-Venereologica) – double-blind RCT, 289 patients. 20% azelaic acid versus 5% benzoyl peroxide. At 6 months, comparable reduction in papule and pustule counts, with less irritation in the azelaic group.
Iraji et al., 2007 – 20% azelaic acid versus 0.05% tretinoin for papulopustular acne. At 12 weeks, comparable efficacy, with better tolerability in the azelaic arm.
Systematic review by Liu et al., 2020 – azelaic acid 15–20% sits in first-line therapy for mild-to-moderate acne, particularly for patients who don't tolerate retinoids and for pregnancy.
Rosacea (papulopustular)
Thiboutot et al., 2003 (JAAD) – multicentre RCT, 329 rosacea patients. 15% azelaic gel versus vehicle, 12 weeks. 61% in the active arm reached significant improvement versus 40% in vehicle.
Elewski et al., 2003 – 15% azelaic gel versus 0.75% metronidazole gel. Azelaic showed slightly better outcomes on papule count and erythema.
On the basis of these trials FDA approved 15% azelaic gel (Finacea) for papulopustular rosacea in 2002. In Russia the same indication is registered for Skinoren 15% gel.
Post-inflammatory hyperpigmentation and melasma
Kakita & Lowe, 2002 – 20% azelaic acid versus 4% hydroquinone for melasma in dark skin (Fitzpatrick IV–VI). At 6 months, comparable lightening, with no risk of ochronosis on the azelaic arm.
Trade-off: hydroquinone works faster, but has duration limits (≤3 months) and a risk of paradoxical darkening. Azelaic is slower but safer over the long run.
Concentrations: what to buy
| Form | Concentration | Indication | Where |
|---|---|---|---|
| Pharmacy gel/cream | 15–20% | Acne, rosacea, melasma | Finacea, Skinoren, Azelex |
| Mid-range cosmetic | 10% | Maintenance after a course, mild pigmentation | The Ordinary, Paula's Choice |
| Budget cosmetic | 3–5% | Minimal effect, mostly marketing | various |
5% does not act on inflammation – the trial data underlying current guidelines was run at 15–20%. Concentrations below 15% have not shown effect on acne or rosacea. 10% is a grey zone: may work on pigmentation, no data for acne.
How to introduce it
Azelaic acid does not break down in sunlight (unlike vitamin C) and does not increase photosensitivity (unlike retinoids). Therefore:
- Morning or evening – your call. Many pick evening so the morning slot stays for SPF.
- Start every other day to assess tolerance. About 10–15% of users get mild stinging or burning during the first 1–2 weeks. It's a typical adjustment reaction and resolves on its own.
- After 2 weeks you can move to daily, after 4 to twice daily.
- Pea-sized layer on the whole face. Gel suits oily skin, cream suits dry.
- SPF is mandatory – not because of azelaic itself, but because any acne or rosacea regimen requires UV protection.
Therapeutic effect on acne and rosacea takes 8–12 weeks of consistent use. On pigmentation, 12–24 weeks. Earlier judgements are premature.
What it pairs with, what it doesn't
Good pairings:
- With retinoids – alternate days, or azelaic in the morning, retinoid at night. Different pathogenic targets in acne.
- With niacinamide – niacinamide reinforces the anti-inflammatory effect, azelaic the antibacterial. Safe combination.
- With SPF – mandatory morning pair.
Bad pairings:
- With AHA/BHA in the same application – not forbidden, but the irritation risk goes up. Better to alternate days.
- With physical scrubs – azelaic already addresses keratinisation. Adding mechanical exfoliation is unnecessary and provokes telangiectasias.
Who it's for, who it's not
Good candidates:
- Mild-to-moderate inflammatory acne, particularly with post-acne marks.
- Papulopustular rosacea.
- Pregnancy and breastfeeding – azelaic is permitted (FDA category B), unlike retinoids.
- Sensitive, reactive skin that does not tolerate retinoids or benzoyl peroxide.
- Darker phototypes (IV–VI) with post-inflammatory hyperpigmentation.
Not the right tool:
- Severe nodular or conglobate acne – isotretinoin territory.
- Erythematotelangiectatic rosacea (redness and vessels without papules) – azelaic does not act on the vascular component. IPL or laser plus strict UV protection are the right tools.
- Deep dermal pigmentation – needs more aggressive methods (TCA, laser).
- Known azelaic acid allergy – rare, but reported.
Pregnancy and breastfeeding
Azelaic acid is FDA category B – no controlled studies in pregnant humans, no teratogenic signal in animal studies, and no safety signals after decades of use in people.
This is one of the rare situations where the same ingredient works for pregnancy acne, pregnancy rosacea, and chloasma (pregnancy melasma) – three conditions that often appear or worsen with hormonal shifts. The decision still belongs in conversation with the OB-GYN.
Bottom line
Azelaic acid 15–20% is one of the most versatile pharmacy actives with serious clinical backing. It's not the trendiest ingredient (no bakuchiol-level hype, no exosomes) and not the fastest (tretinoin acts quicker on retention lesions), but on the efficacy-to-safety ratio it sits firmly in first-line therapy for the conditions that account for roughly 70% of dermatology consultations focused on the face.
Cosmetic 5–10% does not treat – it maintains. If the goal is therapeutic, the pharmacy 15–20% is the answer. If the goal is keeping things stable after a course, 10% from Paula's Choice or The Ordinary will do.
One last thing: no topical works as monotherapy for acne or rosacea past a year. If 3 months of consistent use brought no change, it's time for a dermatologist visit, not the next ingredient.